Skip to main content
Figure 2 | Respiratory Research

Figure 2

From: Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema

Figure 2

Phenotypes and Oct-4 mRNA expression of rAFMSCs. (A) The rAFMSCs were phenotypically characterized by means of flow cytometry. The relevant isotype controls were used as the negative control. The surface antigens CD29, CD44, CD73, CD90, CD105, and CD166 were expressed in P3 rAFMSCs, but CD14, CD19, CD34, and CD45 were not. (B) Oct-4 mRNA expression in rAFMSCs was analyzed by performing RT-PCR. Lane 1, rAFMSCs; Lane 2, negative control (rat lung fibroblasts).

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us